Biogen-Idec Earnings Preview (BIIB, DNA)

On Wednesday, we’ll get to see earnings out of Biogen Idec Inc. (NASDAQ: BIIB). The estimates from First Call for the biotech company are $0.80 EPS on $835.16 million in revenues. Estimates for fiscal 2008 are $3.30 EPS on $3.58 billion in revenues. Despite this stock having been much higher, analysts have an average price target north of $61.00. Its hard to blame the analysts for not being more bullish since Biogen failed to attract any serious bidder. Because of that failed bidding process, we’d throw the chart out the window for any long-term patterns and even for longer-term moving…
…
Original Source

  4 February, 2008| Economy | @ 23:31

• VIDEOS
• Economía Blogosfera
• Bitácora
• Economía G . Medios
• Blog de Economía
• Blog Vivienda
• Mercado Divisas
• Agregador Marketing
• El Intercambiador
• Energía, M. Ambiente
• Blog Análisis Técnico
• Canal solidario
• Agregador A.Técnico
• Agregador Motor

• Economy Blogs
• Hedge Funds
• Fundamental Analysis
• Housing Blogs
• Technical Analysis
• Energy Blogs
• Derivatives: Futures
• Marketing Blogs
• Economy Mass Media
• VIDEOS

Categories:

• Economy

Recent Comments

• Daniel: “Kristen,” Ken Stiffed...
• Merfilin: Facebook Cleanup Possible and a Smart ‘Open Web’ Move...
• ArreniaEncani: Time For Yahoo! (YHOO) Board To Wave White Flag...
• studentyahoo: Top 10 Most Searched Stocks on TheStreet.com, Mar. 7...
• Fortino: RevResponse...
• admin: Google and the Aura of Invincibility...

Calendar: